1 / 3

Antidiabetic Drugs Intermediates Production

Huateng Pharma is a full-service CDMO for pharmaceutical intermediates. We can supply key intermediates of antidiabetic drugs with large scarle.

Download Presentation

Antidiabetic Drugs Intermediates Production

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Huateng Pharma https://us.huatengsci.com Antidiabetic Drugs Intermediates Production Huateng Pharma provides a one stop process development service from concept to commercialization. Learn More>>> SGLT2 Inhibitors SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. Canagliflozin Intermediates (5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone CAS NO.1132832-75-7   2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS NO.898566-17-1   2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene CAS NO.1030825-20-7   2-(4-Fluorophenyl)thiophene CAS NO.58861-48-6 Dapagliflozin Intermediates 4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene CAS NO.1103738-29-9 Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-

  2. Huateng Pharma https://us.huatengsci.com CAS NO.461432-23-5 Empagliflozin Intermediates (3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane CAS NO.915095-89-5   (S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene CAS NO.915095-94-2 DPP-4 Inhibitors DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults. Sitagliptin Intermediates 3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride CAS NO.762240-92-6   (R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid CAS NO.486460-00-8 GLP-1 Agonists GLP-1 agonists are used to lower blood sugar levels to treat diabetes type 2 by releasing more insulin into the bloodstream. Semaglutide Intermediates Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH CAS NO.1662688-20-1   tBuO-Ste-Gljavascript:void(0)-OtBu CAS NO.1118767-16-0 AEEA-AEEA CAS NO.1143516-05-5

  3. Huateng Pharma https://us.huatengsci.com   CH2COOH-PEG2-NH2.HCl CAS NO.:134979-01-4   Boc-NH-PEG2-CH2COOH CAS NO.:108466-89-3   Fmoc-NH-PEG2-CH2COOH CAS NO.:166108-71-0   NH2-PEG2-CH2COOH CAS NO.:134978-97-5 Meet Us In Person CPhI North America 2023 25-27 April, 2023 Pennsylvania Convention Center, Philadelphia Booth #322 Request A Meeting CPhI China 2023 19-21 June, 2023 Shanghai New International Expo Center Booth #W1D08 Request A Meeting

More Related